| Name of consultation |
|
Originator |
|
| December 2012 |
|
|
|
| Draft quality indicators for palliative and end of life care |
|
Healthcare Improvement Scotland |
|
November 2012
|
|
|
|
| UKMi and Medicines Optimisation in England |
|
UKMi |
|
| The next phase: Our consultation on our strategy for 2012 to 2016 |
|
CQC |
|
| Performance review of health and care professional regulators |
|
CHRE |
|
| Together for health - delivering end of life care |
|
Welsh Government |
|
| Falsified medicines directive (FMD) |
|
MHRA |
|
| Draft regulations under the National Health Service (Wales) Act 2006 - The National Health Service (Pharmaceutical Services) (Wales) Regulations |
|
NHS Wales |
|
| Controlled drugs (supervision of management and use) regulations 2013 |
|
Department of Health |
|
| Implementation of NSF for diabetes in Wales |
|
National Assembly for Wales |
|
October 2012
|
|
|
|
| Enabling integrated care in Wales |
|
NHS Wales Informatics Service |
|
| Proposals for commissioners to deliver best value |
|
Department of Health |
|
| Protecting and promoting patients’ interests – licensing providers of NHS services |
|
Department of Health |
|
The development and updating of local formularies
|
|
NICE |
|
Better care for patients: defining the role of general practice in 2022 – a call for action
|
|
Royal College of GPs |
|
Early access to medicines scheme in the UK
|
|
MHRA |
|
Access to medical technologies in Wales
|
|
National Assembly for Wales |
|
September 2012
|
|
|
|
Quality in the new health system: Maintaining and improving quality from April 2013
|
|
Department of Health |
|
| Developing our NHS care objectives: A consultation on the draft mandate to the NHS Commissioning Board |
|
Department of Health |
|
| Joint Strategic Needs Assessments and Joint Health and Wellbeing Strategies |
|
Department of Health |
|
| Information: to share or not to share? Information Governance Review |
|
Department of Health |
|
| Integration of health and social care |
|
Scottish Government |
|
| August 2012 |
|
|
|
| How to change the legal classification of a medicine in the UK |
|
MHRA |
|
| Liberating the NHS: No decision about me, without me. Further consultation on proposals to shared decision-making |
|
Department of Health |
|
| Clarityn Allergy 1mg/ml Syrup (Loratidine) 70ml Pack Size |
|
MHRA |
|
| July 2012 |
|
|
|
| GPHC draft Amendment to Rules consultation 2012 |
|
General Pharmaceutical Council |
|
| Fair Playing Field – for the benefit of patients |
|
Monitor |
|
| Carbon Footprinting Pharmaceuticals and Medical Devices |
|
NHS Sustainable Development Unit |
|
| June 2012 |
|
|
|
| Healthy Lives, Healthy People: Towards a workforce strategy for the public health system |
|
Department of Health |
|
|
Dyspepsia/GORD
|
|
NICE |
|
| Regulation of Health Professionals |
|
Law Commission |
|
| May 2012 |
|
|
|
| Making Things Better – Improving the ways we deal with complaints and concerns about social services in Wales |
|
Welsh Government |
|
| Social Services (Wales) Bill Consultation |
|
Welsh Government |
|
| Modernising pharmacy regulation: A consultation on the draft standards for registered pharmacies |
|
General Pharmaceutical Council |
|
| April 2012 |
|
|
|
| Pharmaceutical Services Regulations |
|
Welsh Government |
|
| March 2012 |
|
|
|
|
Call for Evidence on induction for doctors new to practising in the UK
|
|
GMC |
|
|
Draft 2012 fees rules for the General Pharmaceutical Council
|
|
General Pharmaceutical Council |
|
| Neutropenic Sepsis |
|
NICE |
|
| ARM 81 Imodium Instants (loperamide hydrochloride) 12 tablet pack size |
|
MHRA |
|
February 2012 |
|
|
|
| Transposition of Pharmacovigilance Consultation MLX 374 |
|
MHRA |
|
| Consultation on potential COF indicators |
|
NICE
|
|
| Good Medical Practice |
|
GMC |
|
|
80 Clarityn Allergy 10mg Tablets (Loratidine) 30 Tablet Pack Size
Request to reclassify a product from P to GSL
|
|
MHRA |
|
| Potential new indicators for the 2013/14 Quality and Outcomes Framework (QOF) |
|
NICE |
|
January 2012 |
|
|
|
| Implementing a Duty of Candour - a new contractual requirement on providers |
|
Department of Health |
|
| Draft regulations under the Health Act 2009: Market entry by means of pharmaceutical needs assessments and quality and performance |
|
PNA
|
|
| Service standards on confidentiality |
|
Faculty of Sexual and Reproduction Healthcare
|
|
| Cost effectiveness and efficiency in health professional regulation |
|
CHRE
|
|
| Medicines Act consultation |
|
MHRA
|
|
| NICE's proposals for changes to the process and methods for public health guidance development |
|
NICE
|
|
